AIM IMMUNOTECH INC. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/48265bf4-3453-4bc3-a500-05dc64e74166/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $88.0k | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-013301 |
| FY 2024 | $170.0k | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-000847 |
| FY 2023 | $202.0k | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012058 |
| FY 2022 | $141.0k | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-010351 |
| FY 2021 | $135.0k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-008324 |
| FY 2020 | $163.0k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-007259 |
| FY 2019 | $140.0k | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-005290 |
| FY 2018 | $367.0k | 2018-01-01 – 2018-12-31 | evidence 0001493152-20-005290 |
| FY 2017 | $437.0k | 2017-01-01 – 2017-12-31 | evidence 0001493152-19-004583 |
| FY 2016 | $92.0k | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003242 |
| FY 2015 | $133.0k | 2015-01-01 – 2015-12-31 | evidence 0001615774-16-004671 |
| FY 2014 | $197.0k | 2014-01-01 – 2014-12-31 | evidence 0001615774-16-004671 |
| FY 2013 | $150.0k | 2013-01-01 – 2013-12-31 | evidence 0001615774-16-004671 |
| FY 2012 | $213.0k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-015749 |
| FY 2011 | $161.0k | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-014793 |
| FY 2010 | $135.0k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-014793 |
| FY 2009 | $111.0k | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-014793 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AIM IMMUNOTECH INC. — all facts · Net Income · Operating Income